Hemodialysis and Peritoneal Dialysis Market Report 2026-2031, By Product, Modality, and Geo

Q: Which region accounted for the largest share of the hemodialysis and peritoneal dialysis market in 2025?

North America accounted for approximately 46.2% of the global hemodialysis and peritoneal dialysis market in 2025, making it the leading regional market. Read More

Q: Which hemodialysis consumable type is expected to witness the fastest growth during the forecast period?

HD access products are projected to register the highest CAGR of 10.6% from 2026 to 2031 among hemodialysis consumable types. Read More

Q: Which hemodialysis service type is expected to grow at the highest rate through 2031?

Home hemodialysis (HHD) services are projected to register the highest CAGR of 11.4% from 2026 to 2031 among hemodialysis service types. Read More

Q: Which peritoneal dialysis modality held the largest share of the market in 2025?

Automated peritoneal dialysis (APD) accounted for the largest share of the peritoneal dialysis market in 2025. Read More

Q: Who are the key players operating in the global hemodialysis and peritoneal dialysis market?

Key players profiled include Fresenius Medical Care, Vantive, B. Braun, Nipro Corporation, Nikkiso Co., Ltd., DaVita Inc., Asahi Kasei Medical Co., Ltd., Toray Medical Co., Ltd., JMS Co., Ltd., Outset Medical, Rockwell Medical, AWAK Technologies, Medivators, Becton, Dickinson and Company, and Medtronic plc. Read More

DESCRIPTION
TABLE OF CONTENTS
METHODOLOGY
DOWNLOAD PDF

Hemodialysis & Peritoneal Dialysis Market by Product (Hemodialysis Equipment, Dialysates, PD Machine, Consumables), Modality (CAPD, APD, SDHD, Conventional HD, Nocturnal HD), Disease Indication (CKD, ESRD, AKI), End User, Region - Global Forecast to 2031

$102.7B

MARKET SIZE, 2026

$141.5B

MARKET SIZE, 2031

6.6%

CAGR (2026-2031)

2026-2031

FORECAST PERIOD

HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, SHARE & GROWTH SNAPSHOT

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global hemodialysis and peritoneal dialysis market is projected to grow from USD 102.7 billion in 2026 to USD 141.5 billion by 2031, at a CAGR of 6.6% during the forecast period. The market was valued at USD 97.2 billion in 2025. Revenue growth in the hemodialysis and peritoneal dialysis market is increasingly shifting toward home-based care solutions, advanced therapy management platforms, and technology-enabled treatment models. The rising prevalence of chronic kidney disease and end-stage renal disease, driven by increasing rates of diabetes, hypertension, and aging populations worldwide, is expanding the global patient base. Market revenue opportunities are further shifting toward emerging markets, including Asia Pacific, Latin America, and the Middle East & Africa, due to expanding dialysis infrastructure and improving access to renal care. Additionally, the integration of Artificial Intelligence-assisted therapy management, remote patient monitoring platforms, and automated peritoneal dialysis cyclers is accelerating the adoption of home-based dialysis solutions. The transition toward value-based kidney care is further strengthening demand for home hemodialysis and automated peritoneal dialysis as commercially important treatment approaches for payers and healthcare providers globally.

KEY TAKEAWAYS

MARKET SNAPSHOT:
Base Year Market Size (2025): USD 97.2 Billion
Current Market Size (2026): USD 102.7 Billion
Forecast Market Size (2031): USD 141.5 Billion
CAGR (2026–2031): 6.6%
SEGMENT LEADERSHIP:
Regional Leader: North America accounted for approximately 46.2% of the hemodialysis and peritoneal dialysis market in 2025.
Fastest-Growing HD Consumable Type: HD access products are projected to register the highest CAGR of 10.6% from 2026 to 2031.
Fastest-Growing HD Service Type: Home hemodialysis (HHD) services are projected to grow at the highest CAGR of 11.4% from 2026 to 2031.
PD Modality Leader: Automated peritoneal dialysis (APD) accounted for the largest share in 2025.
Disease Indication Leader: End-stage renal disease (ESRD) accounted for the largest share of 53.5% in 2025.
End User Leader: Hospitals held the largest share in 2025.
MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
Fresenius Medical Care (Germany), Vantive (US), B. Braun (Germany), Nipro Corporation (Japan), and Nikkiso Co., Ltd. (Japan) were identified as star players, given their vertically integrated product-to-service portfolios and global dialysis center networks.
Rockwell Medical (US), Outset Medical (US), and AWAK Technologies (Singapore) have distinguished themselves among emerging players by offering specialized products for home dialysis, portable systems, and wearable PD devices.

The hemodialysis and peritoneal dialysis market is expanding steadily, attributed to the structural growth of the ESRD patient population and rising government investment in renal care infrastructure. Advances in dialyzer membrane technology, including the clinical adoption of medium-cut-off membranes for expanded hemodialysis, along with the wider rollout of cloud-connected APD cyclers and home HD systems with digital monitoring, are promoting adoption across hospitals, independent dialysis centers, and home care settings. These dynamics collectively support sustained market growth through the forecast period.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

Manufacturers and service providers in the hemodialysis and peritoneal dialysis space currently derive the majority of their revenues from established product lines: in-center hemodialysis systems and consumables, conventional dialyzers, bloodlines, concentrates, vascular access products, and standard peritoneal dialysis solutions with manual CAPD consumables. This base accounts for roughly 80% of today's revenue mix. The remaining 20% reflects the early but accelerating commercialization of next-generation offerings. New use cases in remote and home-based care, new technologies including high-flux and high-efficiency dialyzers and HDF-enabled systems, an expanding ecosystem of digital care platforms, and new client partnerships with home care providers and value-based kidney care operators are together driving a material shift. Targeted acquisitions, like Vantive's separation from Baxter and its investment in the HomeAdvantage digital ecosystem, illustrate how the revenue mix of the future will be weighted toward connected, home-enabled, and data-driven therapies.

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers

Impact
Level

Increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) due to diabetes, hypertension, and aging populations
Rising adoption of dialysis treatment worldwide, supported by expanding access to renal care infrastructure

RESTRAINTS

Impact
Level

High cost of dialysis equipment, consumables, and long-term treatment
Limited access to advanced dialysis infrastructure and trained nephrology staff in low-resource regions

OPPORTUNITIES

Impact
Level

Technological advancements in home hemodialysis, automated peritoneal dialysis (APD), and connected dialysis platforms
Increasing demand for remote monitoring, tele-nephrology, and portable/compact dialysis systems

CHALLENGES

Impact
Level

Risk of infection, vascular access complications, and peritonitis
Need for strong patient training, adherence, and home-care support

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) due to diabetes, hypertension, and aging populations

Chronic kidney disease is one of the most structurally persistent drivers of demand in the global dialysis market. More than 808,000 people in the US are living with ESRD, of whom 68% receive dialysis, according to the US Renal Data System 2023 Annual Data Report. The convergence of aging demographics, rising rates of type 2 diabetes, and hypertension is producing a growing pool of patients who will require long-term renal replacement therapy. In Asia Pacific and Latin America, urbanization-linked lifestyle shifts are driving CKD prevalence faster than public health systems can expand dialysis capacity. This structural deficit in dialysis supply relative to patient demand provides a long-duration demand tailwind for hemodialysis machines, dialyzers, consumables, PD products, and dialysis services across both established and emerging markets.

Restraint: High cost of dialysis equipment, consumables, and long-term treatment

The per-patient cost of maintenance dialysis remains a substantial barrier to access and market penetration in lower-income regions. In-center hemodialysis in the US costs approximately USD 90,000 per patient per year, and home hemodialysis systems carry significant upfront capital requirements for both patients and providers. In low- and middle-income countries, the cost of dialysis machines, single-use consumables, and water treatment infrastructure places renal replacement therapy beyond the reach of many patients without government subsidy programs. Reimbursement disparities between in-center and home hemodialysis, particularly in markets outside North America and Western Europe, further slow the transition to home-based modalities where clinical outcomes and long-term cost efficiency are superior.

Opportunity: Technological advancements in home hemodialysis, automated peritoneal dialysis (APD), and connected dialysis platforms

The integration of digital connectivity, remote monitoring, and automated pre-treatment functionality into dialysis devices is creating a generation of products that are both clinically superior and commercially differentiated. Fresenius Medical Care's Kinexus platform, launched globally in June 2026, and Vantive's HomeAdvantage ecosystem, introduced at ASN Kidney Week 2025, exemplify the shift toward unified digital platforms that connect device performance data with care team oversight in real time. The FDA clearance of Nikkiso's DBB-06 PRO with D-FAS full-assist functionality for the US market in May 2025 addresses a long-standing clinical need by reducing pre-treatment setup burden on dialysis nurses. The growing need among health systems for integrated care management platforms creates an opportunity for manufacturers to bundle hardware, software, and services into recurring-revenue contracts that deepen customer relationships and improve patient outcomes.

Challenge: Risk of infection, vascular access complications, and peritonitis

Clinical complication rates remain a structural challenge in both hemodialysis and peritoneal dialysis. Vascular access-related infections are the second most common cause of hospitalization among hemodialysis patients, and fistula failure rates affect outcomes and consumable cycles. Peritonitis remains the leading cause of PD technique failure globally. For manufacturers, these rates translate into post-market surveillance obligations and ongoing investment in membrane biocompatibility. For care providers, complication management determines reimbursement performance under value-based contracts and the CMS ESRD Quality Incentive Program.

HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY	USE CASE DESCRIPTION	BENEFITS
	Provides hemodialysis machines, dialyzers, consumables, and home dialysis solutions for ESRD management.	Improves treatment efficiency, expands home care access, and enhances patient outcomes.
	Offers peritoneal dialysis solutions, cyclers, and automated PD systems for home-based renal replacement therapy.	Enables patient independence, reduces hospital visits, and supports flexible treatment schedules.
	Supplies dialysis machines, concentrates, and renal care products for hospitals and dialysis centers.	Enhances operational efficiency and delivers reliable dialysis treatment.
	Provides dialyzers, blood tubing sets, dialysis machines, and vascular access products.	Supports high-quality dialysis care and improves treatment safety.
	Develops advanced hemodialysis and hemodiafiltration systems with digital monitoring capabilities.	Improves treatment precision, workflow efficiency, and patient management.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The hemodialysis and peritoneal dialysis market ecosystem encompasses manufacturers of HD machines, dialyzers, and consumables; PD product and cycler suppliers; dialysis water treatment system providers; in-center and home dialysis service operators; regulatory bodies governing device safety and reimbursement policy; and a diverse end-user base spanning hospitals, independent dialysis centers, and home care settings. These groups interact through supply agreements, reimbursement systems, clinical training programs, and digital care platforms that connect device performance to care team oversight. The incumbent tier of the ecosystem is dominated by Fresenius Medical Care (Germany), Vantive (formerly Baxter Kidney Care, US), B. Braun (Germany), Nipro Corporation (Japan), and Nikkiso Co., Ltd. (Japan). These companies each operate across the full product spectrum from machines and dialyzers to consumables, water treatment, and services. Fresenius Medical Care operates approximately 3,600 dialysis centers globally and is undertaking the largest HD machine infrastructure upgrade in its history with the 2026 rollout of the 5008X CAREsystem. Vantive separated from Baxter in February 2025 following a USD 3.8 billion acquisition by Carlyle Group, establishing a standalone kidney care company with over 23,000 employees. The specialist tier includes Asahi Kasei Medical, Toray Medical, JMS Co., Outset Medical, Rockwell Medical, and AWAK Technologies, each focusing on high-performance dialyzers, specialized HD platforms, or portable and wearable dialysis systems. Consolidation momentum is visible in Nipro's December 2024 acquisition of a dialysis RO equipment manufacturer in China and Vantive's October 2025 collaboration with US Renal Care to expand home PD access across 32 US states.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Hemodialysis and Peritoneal Dialysis Market, By Disease Indication

End-stage renal disease (ESRD) accounted for the largest share of the hemodialysis and peritoneal dialysis market in 2025. ESRD drives the majority of long-term dialysis demand because patients require ongoing renal replacement therapy for the duration of their lives in the absence of a transplant. The structural growth of the ESRD patient population, linked to rising rates of type 2 diabetes and hypertension across high-burden markets, sustains a large and expanding volume of hemodialysis and PD sessions globally. ESRD is projected to grow at the fastest rate among disease indications. This is driven by improvements in early detection programs, which increase the number of CKD patients in the ESRD registry and by the expansion of reimbursement coverage in emerging markets.

Hemodialysis and Peritoneal Dialysis Market, By HD Service Type

In-center hemodialysis services held the largest share of the HD services market in 2025, reflecting the established infrastructure of over 7,600 CMS-recognized ESRD facilities in the US alone and the widespread clinic-based delivery model globally. In-center HD is the default treatment setting for the majority of prevalent ESRD patients because it does not require patients to operate equipment independently or manage their own supply chains. Home hemodialysis (HHD) services, while currently at a 5.4% share, are projected to grow at an 11.4% CAGR from 2026 to 2031. The CY 2025 ESRD PPS final rule extended Medicare payment to home dialysis for AKI patients, and CMS's ESRD Treatment Choices (ETC) Model continues to apply payment adjustments that incentivize providers to transition eligible patients to home modalities.

Hemodialysis and Peritoneal Dialysis Market, By End User

Hospitals held the largest end-user share in 2025, driven by their role as the primary point of care for newly incident ESRD patients, AKI patients in intensive care requiring CRRT, and patients with significant comorbidities who require supervised treatment. Independent dialysis centers collectively accounted for 49.1% but are distributed across a highly fragmented operator landscape. Home care settings are the fastest-growing end-user segment, as healthcare systems under cost-containment pressure increasingly view home dialysis as a more sustainable care model. Policy support from CMS and provider-level investment by operators like Fresenius Medical Care and Vantive in home therapy ecosystems are converting this preference into commercial volume.

REGION

Asia Pacific to be fastest-growing region in global hemodialysis and peritoneal Dialysis market during forecast period

Asia Pacific is the fastest-growing regional market in the hemodialysis and peritoneal dialysis space. China, India, Japan, South Korea, and Australia are the primary contributors to this growth trajectory. China is the fastest-growing country in the region, driven by the government's universal rural ESRD coverage program and the National Medical Products Administration's volume-based procurement policies, which have expanded patient access to dialysis treatment across tier-2 and tier-3 cities. India's Pradhan Mantri National Dialysis Programme (PMNDP) subsidizes dialysis costs for patients below the poverty line, accelerating the enrollment of previously unserved patients into the formal dialysis system. Japan maintains the highest dialysis prevalence globally, with over 95% of patients receiving in-center treatment in certified facilities under the Japanese Society for Dialysis Therapy's standards. Increasing healthcare expenditure, improving access to advanced medical technologies, and a growing private dialysis center sector across Southeast Asia are adding to regional growth. The combination of a structurally large unmet need, government-driven capacity expansion, and the entry of global manufacturers with competitively priced systems for emerging markets positions Asia Pacific as the most commercially dynamic region through 2031.

HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY EVALUATION MATRIX

The hemodialysis and peritoneal dialysis market's competitive landscape is assessed across two dimensions: market share and rank (vertical axis) and product footprint breadth (horizontal axis). Fresenius Medical Care occupies the Stars quadrant, combining the broadest product footprint in the market, spanning HD machines, dialyzers, consumables, water treatment systems, and home dialysis platforms, with the highest market share. The company operates a global clinic network of approximately 3,600 dialysis centers and is executing the rollout of the 5008X CAREsystem across 28 US states in 2026, together with the global launch of the Kinexus digital home dialysis platform. Its R&D infrastructure spans sites in Germany, the US, and China, ensuring continuous pipeline replenishment. Rockwell Medical occupies the Emerging Leaders quadrant, with a focused position in hemodialysis concentrates and dialysate products. The company's specialized product range addresses the recurring consumable demand at dialysis centers and reflects the segment's high CAGR profile as dialysis treatment volumes grow globally. Rockwell Medical's concentrated geographic presence in the US, together with a cost-competitive offering in a recurring-purchase category, positions it as a focused growth player rather than a broad-portfolio incumbent.

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

Fresenius Medical Care (Germany)
Vantive (US)
B. Braun (Germany)
Nipro Corporation (Japan)
Nikkiso Co., Ltd. (Japan)
DaVita Inc. (US)
Asahi Kasei Medical Co., Ltd. (Japan)
Toray Medical Co., Ltd. (Japan)
JMS Co., Ltd. (Japan)
Outset Medical (US)
Rockwell Medical (US)
AWAK Technologies (Singapore)
Medivators (US)
Becton, Dickinson and Company (US)
Medtronic plc (Ireland)

MARKET SCOPE

REPORT METRIC	DETAILS
Base Year	2025
Base Year Market Size (2025)	USD 97.2 Billion
Current Market Size (2026)	USD 102.7 Billion
Projected Market Size (2031)	USD 141.5 Billion
Growth Rate	CAGR of 6.6% from 2026–2031
Forecast Period	2026–2031
Years Considered	2024–2031
Units Considered	Value (USD Million/Billion), Volume (Thousand Units)
Report Coverage	Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends
Segments Covered	By Product & Service, HD Product & Service, PD Product & Service, HD Modality, PD Modality, Disease Indication, End User, and Region
Regional Scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Report Code	MD 2157
Published	2026-06-29
Prepared By	MarketsandMarkets™ Healthcare Research Team
Last Reviewed	2026-07-24

WHAT IS IN IT FOR YOU: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET REPORT CONTENT GUIDE

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST	CUSTOMIZATION DELIVERED	VALUE ADDS
Product Analysis	Comparative analysis of key hemodialysis and peritoneal dialysis product subsegments, including HD machines (center-use vs. home-use), dialyzers (high-flux, MCO/HDx), bloodlines, concentrates, HD access products, PD machines, and PD catheters Highlighted technology trends, including connected APD cyclers and MCO membrane dialyzers.	Enabled identification of high-growth consumable segments, technology adoption patterns, and product performance differentiation, supporting decisions on portfolio investment, innovation priorities, and procurement strategy.
Company Information	Detailed competitive profiling of Fresenius Medical Care, Vantive, B. Braun, Nipro Corporation, and Nikkiso Co., Ltd. Provided analysis of product portfolios, recent developments (Kinexus platform, HomeAdvantage ecosystem, DBB-06 PRO US launch), and competitive positioning across North America and Asia Pacific.	Delivered clarity on partnership, acquisition, and licensing opportunities in home dialysis Supported competitive benchmarking for go-to-market strategy across HD machines and PD consumables segments.
Geographic Analysis	Detailed country-level analysis of Rest of Asia Pacific markets, including India, South Korea, Australia, Thailand, Vietnam, Malaysia, and Indonesia Assessed country-level demand factors, including PMNDP subsidies in India, volume-based procurement policies in China, and private dialysis center expansion across Southeast Asia.	Supported regional market entry and expansion strategies by identifying priority country markets, localization requirements, distribution partnership structures, and pricing dynamics relevant to emerging market dialysis operators.

RECENT DEVELOPMENTS

June 2026 : Fresenius Medical Care launched Kinexus globally, a unified digital platform designed to support home dialysis programs. The platform connects patients, care teams, and dialysis devices through a single interface, providing remote monitoring and access to therapy data. The Kinexus launch follows the company's US rollout of the 5008X CAREsystem for high-volume hemodiafiltration and represents the company's digital layer investment for the home dialysis segment.
March 2026 : Vantive announced an expansion of its US home therapy innovation strategy, adding digitally integrated capabilities to its HomeAdvantage ecosystem. Enhancements rolling out from April 2026 include Vantive CONNECT Success, an end-to-end proactive support model for peritoneal dialysis patients, and expanded remote monitoring and analytics capabilities within the Vantive CONNECT platform. The update builds on the fall 2025 launch of HomeAdvantage and aims to improve patient confidence and adherence in home PD.
December 2025 : Nikkiso announced the launch of its DBB-06 PRO hemodialysis machine and dedicated bloodline set for the US market, with commercial availability from January 2026. The DBB-06 PRO is the first hemodialysis machine for the US market to incorporate Nikkiso's D-FAS (Dialysis Full Assist System), which automates pre-treatment priming to reduce clinical staff burden. The machine and its Arch Loop bloodline set received FDA clearance in May 2025 and are manufactured at the Kanazawa Plant in Japan.

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE

PAGE NO

INTRODUCTION

EXECUTIVE SUMMARY

PREMIUM INSIGHTS

MARKET OVERVIEW

Technological advancements and aging demographics drive demand in the dialysis market despite high costs.

4.1

INTRODUCTION

4.2

MARKET DYNAMICS

4.2.1

DRIVERS

4.2.1.1

RISING PREVALENCE OF CHRONIC KIDNEY DISEASE AND END-STAGE RENAL DISEASE

4.2.1.2

INCREASING AGING POPULATION SUSCEPTIBLE TO KIDNEY DISORDERS

4.2.1.3

GROWING PREVALENCE OF DIABETES AND HYPERTENSION

4.2.1.4

CONTINUOUS TECHNOLOGICAL ADVANCEMENTS IN DIALYSIS MACHINES AND CONSUMABLES

4.2.2

RESTRAINTS

4.2.2.1

HIGH COST OF DIALYSIS TREATMENT AND INFRASTRUCTURE

4.2.2.2

FREQUENT PRODUCT RECALLS AND QUALITY COMPLIANCE ISSUES

4.2.3

OPPORTUNITIES

4.2.3.1

EXPANSION OF DIALYSIS CENTERS AND RENAL CARE INFRASTRUCTURE

4.2.3.2

INVESTMENTS IN HEALTHCARE INFRASTRUCTURE IN EMERGING MARKETS

4.2.4

CHALLENGES

4.2.4.1

SHORTAGE OF NEPHROLOGISTS AND TRAINED DIALYSIS PROFESSIONALS

4.2.4.2

RISK OF DIALYSIS-RELATED INFECTIONS AND COMPLICATIONS

4.3

UNMET NEEDS AND WHITE SPACES

4.3.1

UNMET NEEDS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET

4.3.2

WHITE SPACE OPPORTUNITIES

4.4

INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES

4.4.1

INTERCONNECTED MARKETS

4.4.2

CROSS-SECTOR OPPORTUNITIES

4.5

STRATEGIC MOVES BY TIER 1/2/3 PLAYERS

4.5.1

STRATEGIC MOVES IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET

INDUSTRY TRENDS

Navigate competitive landscapes with strategic insights on market forces and global healthcare trends.

5.1

PORTER’S FIVE FORCES ANALYSIS

5.1.1

THREAT OF NEW ENTRANTS

5.1.2

THREAT OF SUBSTITUTES

5.1.3

BARGAINING POWER OF SUPPLIERS

5.1.4

BARGAINING POWER OF BUYERS

5.1.5

INTENSITY OF COMPETITIVE RIVALRY

5.2

MACROECONOMIC INDICATORS

5.2.1

INTRODUCTION

5.2.2

GDP TRENDS AND FORECAST

5.2.3

TRENDS IN GLOBAL HEALTHCARE INDUSTRY

5.2.4

TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY

5.3

SUPPLY CHAIN ANALYSIS

5.4

VALUE CHAIN ANALYSIS

5.5

ECOSYSTEM ANALYSIS

5.5.1

MANUFACTURERS

5.5.2

END USERS

5.5.3

REGULATORY BODIES

5.6

PRICING ANALYSIS

5.7

TRADE ANALYSIS

5.7.1

IMPORT DATA (HS CODE 9018)

5.7.2

EXPORT DATA FOR (HS CODE 9018)

5.8

REIMBURSEMENT SCENARIO

5.9

KEY CONFERENCES AND EVENTS, 2026–2027

5.10

TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS

5.11

INVESTMENT AND FUNDING SCENARIO

5.12

CASE STUDY ANALYSIS

5.13

IMPACT OF 2025 US TARIFF - HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET

5.13.1

INTRODUCTION

5.13.2

KEY TARIFF RATES

5.13.3

PRICE IMPACT ANALYSIS

5.13.4

IMPACT ON COUNTRIES/REGIONS

5.13.5

IMPACT ON END-USE SEGMENTS

5.13.5.1

HOSPITALS

5.13.5.2

INDEPENDENT DIALYSIS CENTERS

5.13.5.3

HOME CARE SETTINGS

5.13.5.4

OTHER END USERS

TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

AI-driven innovations revolutionize dialysis with personalized, remote, and wearable tech advancements.

6.1

TECHNOLOGY ANALYSIS

6.1.1

KEY EMERGING TECHNOLOGIES

6.1.1.1

HIGH-VOLUME HEMODIAFILTRATION (HDF)

6.1.1.2

INTELLIGENT HOME DIALYSIS PLATFORMS

6.1.2

COMPLEMENTARY TECHNOLOGIES

6.1.2.1

REMOTE PATIENT MANAGEMENT PLATFORMS

6.1.2.2

ADVANCED DIALYZER MEMBRANE TECHNOLOGY

6.1.3

ADJACENT TECHNOLOGIES

6.1.3.1

PORTABLE & WEARABLE ARTIFICIAL KIDNEY TECHNOLOGIES

6.2

TECHNOLOGY/PRODUCT ROADMAP

6.2.1

NEAR TERM (2025–2027)

6.2.2

MID-TERM (2028–2030)

6.2.3

LONG TERM (2030+)

6.3

PATENT ANALYSIS

6.3.1

JURISDICTION AND TOP APPLICANT ANALYSIS

6.4

FUTURE APPLICATIONS

6.4.1

AI-ASSISTED TREATMENT PLANNING AND THERAPY OPTIMIZATION

6.4.2

PERSONALIZED DIALYSIS THERAPY

6.4.3

CONNECTED DIALYSIS WORKFLOWS AND DIGITAL INTEGRATION

6.5

IMPACT OF AI/GEN AI ON HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET

6.5.1

INTRODUCTION

6.5.2

MARKET POTENTIAL OF AI IN HEMODIALYSIS AND PERITONEAL DIALYSIS

6.5.3

AI USE CASES

6.5.4

KEY COMPANIES IMPLEMENTING AI

REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES

Navigate global regulations and sustainability efforts to enhance eco-friendly practices in your industry.

107

7.1

REGULATORY LANDSCAPE

7.1.1

REGULATORY FRAMEWORK

7.1.1.1

NORTH AMERICA

7.1.1.2

EUROPE

7.1.1.3

ASIA PACIFIC

7.1.1.4

LATIN AMERICA

7.1.1.5

MIDDLE EAST & AFRICA

7.1.2

REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

7.1.3

INDUSTRY STANDARDS

7.2

SUSTAINABILITY INITIATIVES

7.2.1

REDUCING MEDICAL WASTE & USE OF LOWER-IMPACT MATERIALS AND PACKAGING

7.2.2

WATER, ENERGY, & RESOURCE EFFICIENCY

7.2.3

CERTIFICATIONS, LABELING, AND ECO-STANDARDS

CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

Navigate complex stakeholder dynamics and unmet needs to unlock market profitability.

114

8.1

DECISION-MAKING PROCESS

8.2

KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR CRITERIA

8.2.1

KEY STAKEHOLDERS IN BUYING PROCESS

8.2.2

BUYING CRITERIA

8.3

ADOPTION BARRIERS AND INTERNAL CHALLENGES

8.4

UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES

8.5

MARKET PROFITABILITY

HEMODIALYSIS MARKET, BY PRODUCT & SERVICE

Market Size & Growth Rate Forecast Analysis to 2031 in USD Billion and Units | 68 Data Tables

119

9.1

INTRODUCTION

9.2

HEMODIALYSIS SERVICES

9.2.1

IN—CENTER HEMODIALYSIS SERVICES

9.2.1.1

GROWING GERIATRIC POPULATION AND INCREASING GOVERNMENT HEALTHCARE EXPENDITURE TO DRIVE SEGMENT

9.2.2

HOME HEMODIALYSIS SERVICES

9.2.2.1

POOR REIMBURSEMENT SCENARIO AND HIGH TREATMENT COSTS TO LIMIT MARKET GROWTH

9.3

HEMODIALYSIS PRODUCTS

9.3.1

HEMODIALYSIS MACHINES

9.3.1.1

CENTER-USE HEMODIALYSIS MACHINES

9.3.1.1.1

RISING NUMBER OF RENAL CARE CENTERS TO AID SEGMENT GROWTH

9.3.1.1.2

VOLUME ANALYSIS OF CENTER-USE HEMODIALYSIS MACHINES, 2024–2031 (TEN THOUSAND UNITS)

9.3.1.2

HOME-USE HEMODIALYSIS MACHINES

9.3.1.2.1

LESSER HOSPITAL STAYS AND BETTER CLINICAL OUTCOMES TO PROPEL SEGMENT GROWTH

9.3.1.2.2

VOLUME ANALYSIS OF HOME-USE HEMODIALYSIS MACHINES, 2024–2031 (TEN THOUSAND UNITS)

9.3.2

HEMODIALYSIS CONSUMABLES & SUPPLIES

9.3.2.1

DIALYZERS

9.3.2.1.1

DIALYZERS MARKET, BY MATERIAL

9.3.2.1.2

DIALYZERS MARKET, BY FLUX

9.3.2.2

BLOODLINE SETS AND TUBES

9.3.2.2.1

HIGH PRICING AND REDUCED RATE OF REUSE TO LIMIT MARKET EXPANSION

VOLUME ANALYSIS OF BLOODLINE SETS AND TUBES,

9.3.2.3

CONCENTRATES/DIALYSATES

9.3.2.3.1

ALKALINE CONCENTRATES

9.3.2.3.2

ACIDIC CONCENTRATES

9.3.2.4

ACCESS PRODUCTS

9.3.2.4.1

AV FISTULA NEEDLES

9.3.2.4.2

AV GRAFTS

9.3.2.4.3

CENTRAL VENOUS CATHETERS

9.3.2.5

OTHER HEMODIALYSIS CONSUMABLES & SUPPLIES

VOLUME ANALYSIS OF OTHER HEMODIALYSIS CONSUMABLES,

9.4

HEMODIALYSIS MARKET, BY MODALITY

9.4.1

CONVENTIONAL HEMODIALYSIS

9.4.1.1

TECHNOLOGICAL ADVANCEMENTS AND RISING NUMBER OF DIALYSIS CENTERS TO DRIVE SEGMENT

9.4.2

SHORT DAILY HEMODIALYSIS

9.4.2.1

IMPROVED BLOOD PRESSURE CONTROL AND BETTER CALCIUM-PHOSPHORUS BALANCE TO AUGMENT SEGMENT GROWTH

9.4.3

NOCTURNAL HEMODIALYSIS

9.4.3.1

LOWER PROCEDURE COSTS TO AID SEGMENT GROWTH

9.5

HEMODIALYSIS WATER TREATMENT SYSTEMS MARKET, BY TYPE

9.5.1

CENTRAL WATER DISINFECTION SYSTEMS

9.5.1.1

COST-EFFECTIVENESS AND EASY MAINTENANCE TO DRIVE MARKET

9.5.1.1.1

VOLUME ANALYSIS OF CENTRAL WATER DISINFECTION SYSTEMS, 2024-2031 (TEN THOUSAND UNITS)

9.5.2

PORTABLE WATER DISINFECTION SYSTEMS

9.5.2.1

USER-FRIENDLY OPERATIONS AND IMPROVED MICROBIOLOGICAL PURITY TO SUPPORT SEGMENT GROWTH

9.5.2.1.1

VOLUME ANALYSIS OF PORTABLE WATER DISINFECTION SYSTEMS, 2024-2031 (TEN THOUSAND UNITS)

PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE

Market Size & Growth Rate Forecast Analysis to 2031 in USD Billion and Units | 23 Data Tables

175

10.1

INTRODUCTION

10.2

PERITONEAL DIALYSIS PRODUCTS

10.2.1

PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES

10.2.1.1

HIGH DEMAND FOR CONCENTRATES TO BOOST SEGMENT GROWTH

10.2.1.1.1

VOLUME ANALYSIS OF PERITONEAL DIALYSIS CONCENTRATES/ DIALYSATES, 2024-2031 (TEN THOUSAND UNITS)

10.2.2

PERITONEAL DIALYSIS MACHINES

10.2.2.1

RISING PREVALENCE OF CHRONIC DISEASES IN EMERGING ECONOMIES TO BOOST ADOPTION

VOLUME ANALYSIS OF PERITONEAL DIALYSIS MACHINES,

10.2.3

PERITONEAL DIALYSIS CATHETERS

10.2.3.1

FAVORABLE REIMBURSEMENT POLICIES TO SUPPORT MARKET GROWTH

VOLUME ANALYSIS OF PERITONEAL DIALYSIS CATHETERS,

10.2.4

PERITONEAL DIALYSIS TRANSFER SETS

10.2.4.1

INCREASING NUMBER OF PATIENTS IN EMERGING ECONOMIES TO AID MARKET GROWTH

VOLUME ANALYSIS OF PERITONEAL DIALYSIS TRANSFER SETS,

10.2.5

OTHER PERITONEAL DIALYSIS PRODUCTS

VOLUME ANALYSIS OF OTHER PERITONEAL DIALYSIS PRODUCTS,

10.3

PERITONEAL DIALYSIS SERVICES

10.3.1

BETTER PRIVACY AND INCREASED COMFORT OF AT-HOME DIALYSIS TREATMENT TO DRIVE MARKET

10.4

PERITONEAL DIALYSIS MARKET, BY MODALITY

10.4.1

CONTINUOUS AMBULATORY PERITONEAL DIALYSIS

10.4.1.1

SUPERIOR CLEARANCE OF HIGH-MOLECULAR-WEIGHT SUBSTANCES TO DRIVE MARKET

10.4.2

AUTOMATED PERITONEAL DIALYSIS

10.4.2.1

RISK OF RAPID DECLINE IN RESIDUAL RENAL FUNCTIONS TO LIMIT ADOPTION

HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION

Market Size & Growth Rate Forecast Analysis to 2031 in USD Billion | 4 Data Tables

194

11.1

INTRODUCTION

11.2

END-STAGE RENAL DISEASE

11.2.1

RISING GERIATRIC POPULATION AND INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET

11.3

ACUTE KIDNEY INJURY

11.3.1

INCREASING NUMBER OF HOSPITALIZATIONS TO PROPEL MARKET GROWTH

11.4

OTHER INDICATIONS

HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER

Market Size & Growth Rate Forecast Analysis to 2031 in USD Billion | 5 Data Tables

199

12.1

INTRODUCTION

12.2

HOSPITALS

12.2.1

IMPROVED FACILITIES AND INCREASED GOVERNMENT SUPPORT TO DRIVE MARKET

12.3

INDEPENDENT DIALYSIS CENTERS

12.3.1

INCREASED DEMAND FOR ADVANCED DIALYSIS AND END-STAGE RENAL DISEASE TREATMENTS TO PROPEL MARKET GROWTH

12.4

HOME CARE SETTINGS

12.4.1

LOWER COST AND SHORTER HOSPITAL STAYS TO AID MARKET GROWTH

12.5

OTHER END USERS

HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION

Comprehensive coverage of 8 Regions with country-level deep-dive of 18 Countries | 460 Data Tables.

206

13.1

INTRODUCTION

13.2

NORTH AMERICA

13.2.1

MACROECONOMIC OUTLOOK FOR NORTH AMERICA

13.2.2

NORTH AMERICA: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031

13.2.3

13.2.3.1

US TO DOMINATE NORTH AMERICAN MARKET DURING STUDY PERIOD

13.2.4

CANADA

13.2.4.1

SHORTAGE OF DIALYSIS FACILITIES AND INCREASED TREATMENT COST TO RESTRAIN MARKET EXPANSION

13.3

EUROPE

13.3.1

MACROECONOMIC OUTLOOK FOR EUROPE

13.3.2

EUROPE: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031

13.3.3

GERMANY

13.3.3.1

RISING NUMBER OF END-STAGE RENAL DISEASE PATIENTS TO BOOST MARKET GROWTH

13.3.4

13.3.4.1

EXPANDING HOME DIALYSIS PROGRAMS AND STRONG NHS SUPPORT TO DRIVE MARKET

13.3.5

FRANCE

13.3.5.1

STRONG REIMBURSEMENT FRAMEWORK AND GROWING HOME DIALYSIS ADOPTION TO FUEL MARKET

13.3.6

ITALY

13.3.6.1

UNIVERSAL HEALTHCARE COVERAGE AND RISING CKD BURDEN TO SUPPORT MARKET GROWTH

13.3.7

SPAIN

13.3.7.1

INCREASING CKD PREVALENCE AND EXPANDING RENAL CARE INFRASTRUCTURE TO DRIVE MARKET

13.3.8

REST OF EUROPE

13.4

ASIA PACIFIC

13.4.1

MACROECONOMIC OUTLOOK FOR ASIA PACIFIC

13.4.2

ASIA PACIFIC: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031

13.4.3

CHINA

13.4.3.1

EXPANDING DIALYSIS INFRASTRUCTURE AND LARGE CKD PATIENT BASE TO DRIVE MARKET

13.4.4

JAPAN

13.4.4.1

ADVANCED DIALYSIS INFRASTRUCTURE AND UNIVERSAL REIMBURSEMENT TO SUPPORT MARKET GROWTH

13.4.5

INDIA

13.4.5.1

GOVERNMENT-LED DIALYSIS EXPANSION AND RISING CKD BURDEN TO FUEL MARKET

13.4.6

AUSTRALIA

13.4.6.1

HIGH ADOPTION OF HOME DIALYSIS AND STRONG HEALTHCARE SYSTEM TO SUPPORT MARKET GROWTH

13.4.7

SOUTH KOREA

13.4.7.1

GROWING CKD BURDEN AND EXPANDING RENAL CARE SERVICES TO DRIVE MARKET

13.4.8

REST OF ASIA PACIFIC

13.5

LATIN AMERICA

13.5.1

MACROECONOMIC OUTLOOK FOR LATIN AMERICA

13.5.2

LATIN AMERICA: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031

13.5.3

BRAZIL

13.5.3.1

LARGE DIALYSIS PATIENT BASE AND EXPANDING RENAL CARE INFRASTRUCTURE TO DRIVE MARKET

13.5.4

MEXICO

13.5.4.1

HEALTHCARE REFORMS AND EXPANDING ACCESS TO DIALYSIS TO SUPPORT MARKET GROWTH

13.5.5

REST OF LATIN AMERICA

13.6

MIDDLE EAST & AFRICA

13.6.1

MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK

13.6.2

MIDDLE EAST & AFRICA: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024–2031

13.6.3

GCC COUNTRIES

13.6.3.1

KINGDOM OF SAUDI ARABIA (KSA)

13.6.3.1.1

SAUDI VISION 2030 AND EXPANDING DIALYSIS INFRASTRUCTURE TO DRIVE MARKET

13.6.3.2

UNITED ARAB EMIRATES (UAE)

13.6.3.2.1

GROWING INVESTMENTS IN RENAL CARE AND RISING CKD BURDEN TO SUPPORT MARKET GROWTH

13.6.3.3

OTHER GCC COUNTRIES

13.6.4

REST OF MIDDLE EAST & AFRICA

COMPETITIVE LANDSCAPE

Uncover dominant strategies and market leaders shaping the future of dialysis globally.

394

14.1

OVERVIEW

14.2

KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2023–JUNE 2026

14.2.1

OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET

14.3

REVENUE ANALYSIS

14.4

MARKET SHARE ANALYSIS

14.4.1

GLOBAL HEMODIALYSIS MARKET SHARE ANALYSIS, 2025

14.4.1.1

US HEMODIALYSIS MARKET SHARE ANALYSIS, 2025

14.4.1.2

EUROPE HEMODIALYSIS MARKET SHARE ANALYSIS, 2025

14.4.2

GLOBAL PERITONEAL DIALYSIS MARKET SHARE ANALYSIS, 2025

14.4.2.1

US PERITONEAL DIALYSIS MARKET SHARE ANALYSIS, 2025

14.4.2.2

EUROPE PERITONEAL DIALYSIS MARKET SHARE ANALYSIS, 2025

14.5

BRAND/PRODUCT COMPARISON

14.6

COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025

14.6.1

STARS

14.6.2

EMERGING LEADERS

14.6.3

PERVASIVE PLAYERS

14.6.4

PARTICIPANTS

14.6.5

COMPANY FOOTPRINT: KEY PLAYERS, 2025

14.6.5.1

COMPANY FOOTPRINT

14.6.5.2

REGION FOOTPRINT

14.6.5.3

HEMODIALYSIS PRODUCT & SERVICE FOOTPRINT

14.6.5.4

HEMODIALYSIS MODALITY FOOTPRINT

14.6.5.5

HEMODIALYSIS WATER TREATMENT SYSTEM TYPE FOOTPRINT

14.6.5.6

PERITONEAL DIALYSIS PRODUCT & SERVICE FOOTPRINT

14.6.5.7

PERITONEAL DIALYSIS MODALITY FOOTPRINT

14.6.5.8

HEMODIALYSIS AND PERITONEAL DIALYSIS APPLICATION FOOTPRINT

14.6.5.9

HEMODIALYSIS AND PERITONEAL DIALYSIS END USER FOOTPRINT

14.7

COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025

14.7.1

PROGRESSIVE COMPANIES

14.7.2

RESPONSIVE COMPANIES

14.7.3

DYNAMIC COMPANIES

14.7.4

STARTING BLOCKS

14.7.5

COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025

14.7.5.1

DETAILED LIST OF KEY STARTUPS/SMES

14.7.5.2

COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES

14.8

COMPANY VALUATION AND FINANCIAL METRICS

14.8.1

COMPANY VALUATION

14.8.2

FINANCIAL METRICS

14.9

COMPETITIVE SCENARIO

14.9.1

PRODUCT LAUNCHES & APPROVALS

14.9.2

DEALS

14.9.3

EXPANSIONS

14.9.4

OTHER DEVELOPMENTS

COMPANY PROFILES

In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)

422

15.1

KEY PLAYERS

15.1.1

FRESENIUS MEDICAL CARE AG

15.1.1.1

BUSINESS OVERVIEW

15.1.1.2

PRODUCTS/SOLUTIONS/SERVICES OFFERED

15.1.1.3

RECENT DEVELOPMENTS

15.1.1.3.1

PRODUCT LAUNCHES & APPROVALS

15.1.1.3.2

DEALS

15.1.1.3.3

EXPANSIONS

15.1.1.3.4

OTHER DEVELOPMENTS

15.1.1.4

MNM VIEW

15.1.1.4.1

KEY STRENGTHS

15.1.1.4.2

STRATEGIC CHOICES

15.1.1.4.3

WEAKNESSES & COMPETITIVE THREATS

15.1.2

DAVITA INC.

15.1.3

VANTIVE

15.1.4

U.S. RENAL CARE, INC.

15.1.5

B. BRAUN SE

15.1.6

NIPRO CORPORATION

15.1.7

DIAVERUM AB

15.1.8

ASAHI KASEI MEDICAL CO., LTD.

15.1.9

TORAY INDUSTRIES, INC.

15.1.10

NIKKISO CO., LTD.

15.1.11

MOZARC MEDICAL

15.1.12

15.1.13

JMS CO., LTD.

15.1.14

MERIT MEDICAL SYSTEMS

15.1.15

TERUMO CORPORATION

15.2

OTHER PLAYERS

15.2.1

ALLMED MEDICAL PRODUCTS CO., LTD.

15.2.2

OUTSET MEDICAL, INC.

15.2.3

ROCKWELL MEDICAL, INC.

15.2.4

AMERIWATER LLC

15.2.5

DIALIFE SA

15.2.6

QUANTA DIALYSIS TECHNOLOGIES LTD

15.2.7

ISOPURE CORP.

15.2.8

POLY MEDICURE LIMITED

15.2.9

ATLANTIC BIOMEDICAL

15.2.10

AMECATH

RESEARCH METHODOLOGY

490

16.1

RESEARCH DATA

16.1.1

SECONDARY DATA

16.1.1.1

KEY SECONDARY SOURCES

16.1.2

PRIMARY DATA

16.1.2.1

PRIMARY SOURCES

16.1.2.2

KEY DATA FROM PRIMARY SOURCES

16.1.2.3

KEY INDUSTRY INSIGHTS

16.1.2.4

BREAKDOWN OF PRIMARIES

16.2

MARKET SIZE ESTIMATION

16.2.1

APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH

16.2.2

APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION

16.2.3

APPROACH 3: TOP-DOWN APPROACH

16.2.4

APPROACH 4: BOTTOM-UP APPROACH

16.2.5

APPROACH 4: PRIMARY INTERVIEWS

16.2.6

APPROACH 5: DEMAND-SIDE APPROACH

16.2.7

APPROACH 6: VOLUME DATA ANALYSIS

16.3

DATA TRIANGULATION AND MARKET BREAKDOWN

16.4

MARKET SHARE ASSESSMENT

16.5

RESEARCH ASSUMPTIONS

16.5.1

STUDY ASSUMPTIONS

16.5.2

GROWTH RATE ASSUMPTIONS

16.6

RISK ASSESSMENT

16.7

RESEARCH LIMITATIONS

APPENDIX

508

17.1

KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL

17.2

CUSTOMIZATION OPTIONS

17.2.1

PRODUCT ANALYSIS

17.2.2

Methodology

This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

Secondary Research

The research methodology for estimating and forecasting the data center cooling CDU pumps market begins with gathering data on key vendors' revenues by doing secondary research. The secondary research process involves consulting a range of secondary sources, including Hoover's, Bloomberg Businessweek, Factiva, the World Bank, and industry-specific journals. These secondary sources encompass annual reports, press releases, investor presentations, white papers, certified publications, articles from recognized authors, regulatory notifications, trade directories, and databases. Also, vendor offerings are taken into consideration to inform market segmentation.

Primary Research

Primary research for this study was conducted with leading participants across the hemodialysis and peritoneal dialysis value chain. On the supply side, discussions were held with project managers, regional sales managers, product directors, vice presidents of marketing, chief executive officers, and chief information officers at hemodialysis machine manufacturers, dialyzer manufacturers, PD cycler suppliers, consumables providers, water treatment system vendors, and dialysis service operators. On the demand side, interviews were conducted with nephrologists, dialysis center directors, renal care procurement managers, hospital administrators, home dialysis program coordinators, and clinical nursing staff responsible for patient training in home hemodialysis and peritoneal dialysis settings. These interviews were used to validate market size estimates, corroborate segmentation assumptions, and capture the latest commercial dynamics across in-center, home, and acute dialysis care settings.

Hemodialysis and Peritoneal Dialysis Market
Size, and Share

Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 2: Other designations include sales, marketing, and product managers.
Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the hemodialysis & peritoneal dialysis market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

Hemodialysis and Peritoneal Dialysis Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the overall market size using both the market size estimation processes described above, the total market was split into several segments and subsegments. To complete the overall market estimation process and ascertain exact statistics for all segments and subsegments, data triangulation and market breakdowns were applied wherever applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides of the hemodialysis and peritoneal dialysis markets.

Market Definition

The global hemodialysis and peritoneal dialysis market encompasses the revenues generated from the sale and provision of products, equipment, and services used to deliver renal replacement therapy to patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), as well as patients with acute kidney injury (AKI) requiring short-term dialysis support. On the hemodialysis side, the market includes center-use and home-use hemodialysis machines, hemodialysis consumables and supplies (dialyzers, bloodlines and tubing sets, concentrates and dialysates, vascular access products, and other consumables), water treatment systems for dialysis centers (central and portable water disinfection systems), and in-center and home hemodialysis services.

Key Stakeholders

Hemodialysis and peritoneal dialysis machine manufacturers
Dialyzer and hollow-fiber membrane manufacturers
HD consumables and PD product suppliers (bloodlines, concentrates, dialysates, catheters, transfer sets)
Vascular access device manufacturers (AV fistula needles, tunneled catheters, grafts)
Dialysis water treatment system providers
In-center dialysis service operators and dialysis chain operators (independent and hospital-affiliated)
Home dialysis program providers and care management platforms
Nephrologists, renal care nurses, and clinical dietitians
Hospital procurement managers and group purchasing organizations (GPOs)
Government health agencies and reimbursement bodies (CMS, NHS, NHI programs)
Regulatory authorities (US FDA, EMA, CDSCO, PMDA, TGA)
Academic and clinical research institutions focused on nephrology and renal replacement therapy

Report Objectives

To define, describe, segment, and forecast the hemodialysis & peritoneal dialysis market by product & services, disease indication, end user, and region
To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall hemodialysis & peritoneal dialysis market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
To forecast the size of the hemodialysis & peritoneal dialysis market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
To profile the key players in the hemodialysis & peritoneal dialysis market and comprehensively analyze their core competencies and market shares
To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

Available customizations:

Available Customizations

With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

Further breakdown of the Rest of Europe hemodialysis & peritoneal dialysis market into Austria, Finland, Switzerland, and other countries
Further breakdown of the Rest of Latin America hemodialysis & peritoneal dialysis market into Colombia, Chile, and other countries

Competitive Landscape Assessment

Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the Hemodialysis & Peritoneal Dialysis market
Competitive leadership mapping for established players in the US

Key Questions Addressed by the Report

What is the projected growth outlook for the global hemodialysis and peritoneal dialysis market through 2031?

Which region accounted for the largest share of the hemodialysis and peritoneal dialysis market in 2025?

North America accounted for approximately 46.2% of the global hemodialysis and peritoneal dialysis market in 2025, making it the leading regional market. The region’s position is supported by strong adoption of dialysis therapies and established renal care infrastructure.

Which hemodialysis consumable type is expected to witness the fastest growth during the forecast period?

HD access products are projected to register the highest CAGR of 10.6% from 2026 to 2031 among hemodialysis consumable types. The growth is driven by increasing requirements for efficient vascular access solutions in dialysis procedures.

Which hemodialysis service type is expected to grow at the highest rate through 2031?

Home hemodialysis (HHD) services are projected to register the highest CAGR of 11.4% from 2026 to 2031 among hemodialysis service types. The increasing focus on home-based renal care solutions is supporting the growth of this segment.

Which peritoneal dialysis modality held the largest share of the market in 2025?

Automated peritoneal dialysis (APD) accounted for the largest share of the peritoneal dialysis market in 2025. APD is one of the key modalities covered in the hemodialysis and peritoneal dialysis market analysis.

Which disease indication dominated the hemodialysis and peritoneal dialysis market in 2025?

End-stage renal disease (ESRD) accounted for the largest share of the hemodialysis and peritoneal dialysis market, representing 53.5% of the market in 2025. The market analysis covers disease indications including chronic kidney disease (CKD), ESRD, and acute kidney injury (AKI).

Who are the key players operating in the global hemodialysis and peritoneal dialysis market?

Key players profiled in the hemodialysis and peritoneal dialysis market include Fresenius Medical Care, Vantive, B. Braun, Nipro Corporation, Nikkiso Co., Ltd., DaVita Inc., Asahi Kasei Medical Co., Ltd., Toray Medical Co., Ltd., JMS Co., Ltd., Outset Medical, Rockwell Medical, AWAK Technologies, Medivators, Becton, Dickinson and Company, and Medtronic plc.

Which companies are recognized as star players and emerging companies in the dialysis market?

Fresenius Medical Care (Germany), Vantive (US), B. Braun (Germany), Nipro Corporation (Japan), and Nikkiso Co., Ltd. (Japan) were identified as star players due to their vertically integrated product-to-service portfolios and global dialysis center networks. Rockwell Medical (US), Outset Medical (US), and AWAK Technologies (Singapore) have distinguished themselves among emerging players by offering specialized products for home dialysis, portable systems, and wearable PD devices.

REPORT COVERAGE

＋

REPORT OVERVIEW
KEY TAKEAWAYS
TRENDS/DISRUPTIONS IMPACT
MARKET DYNAMICS
MARKET ECOSYSTEM
MARKET SEGMENTS
MARKET REGION
COMPANY EVALUATION MATRIX
KEY MARKET PLAYERS
REPORT SCOPE
WHAT'S IN IT FOR YOU
DELIVERED CUSTOMIZATION
RECENT DEVELOPMENTS

METHODOLOGY

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report

Fact checked

Cite this Research

Adjacent Markets

Request Bundle Reports

Personalize This Research

Triangulate with your Own Data
Get Data as per your Format and Definition
Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
Any level of Personalization

Request A Free Customisation

Let Us Help You

What are the Known and Unknown Adjacencies Impacting the Hemodialysis & Peritoneal Dialysis Market
What will your New Revenue Sources be?
Who will be your Top Customer; what will make them switch?
Defend your Market Share or Win Competitors
Get a Scorecard for Target Partners

Customized Workshop Request

TESTIMONIALS

JAYANT RAJPUROHIT

Director of Market Insights, Data and Analytics

SFI Health,

Leading Pharmaceutical Company

www.sfihealth.com/

We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.

BEATRIZ DE LA CALLE

Head of Commercial Analytics

Qualicaps,

Leading Pharmaceutical Company

www.qualicaps.com/

We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.

Bob Williams,

Senior Director Business Development & Innovation

Bracco Diagnostics Inc.,

Italian Multinational in life sciences sector and a World Leader in imaging diagnostics

imaging.bracco.com/us-en

We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.

Cody Coonradt,

Market Development and Strategy Manager

3M Health Information Systems,

Leader in Health care Coding, Payment & Analytics Solutions.

www.3m.com/3M/en_US/health-information-systems-us

The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.

Their customer first approach and high value engagement model, have given us great analysis and excellent value for money

Growth opportunities and latent adjacency in Hemodialysis & Peritoneal Dialysis Market

Alejandro

Jul, 2020

I would like to know opportunities for growth and adopci�n of peritoneal dialysis in Mexico.

Aaron

Mar, 2022

Looking forward to gain more insights on the global Hemodialysis Market.

Jose

Mar, 2022

Can you enlighten us on the end users in Hemodialysis Market?.

Hemodialysis & Peritoneal Dialysis Market by Product (Hemodialysis Equipment, Dialysates, PD Machine, Consumables), Modality (CAPD, APD, SDHD, Conventional HD, Nocturnal HD), Disease Indication (CKD, ESRD, AKI), End User, Region - Global Forecast to 2031

HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SIZE, SHARE & GROWTH SNAPSHOT

KEY TAKEAWAYS

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

MARKET DYNAMICS

Driver: Increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) due to diabetes, hypertension, and aging populations

Restraint: High cost of dialysis equipment, consumables, and long-term treatment

Opportunity: Technological advancements in home hemodialysis, automated peritoneal dialysis (APD), and connected dialysis platforms

Challenge: Risk of infection, vascular access complications, and peritonitis

HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

MARKET ECOSYSTEM

MARKET SEGMENTS

Hemodialysis and Peritoneal Dialysis Market, By Disease Indication

Hemodialysis and Peritoneal Dialysis Market, By HD Service Type

Hemodialysis and Peritoneal Dialysis Market, By End User

REGION

Asia Pacific to be fastest-growing region in global hemodialysis and peritoneal Dialysis market during forecast period

HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY EVALUATION MATRIX

KEY MARKET PLAYERS

MARKET SCOPE

WHAT IS IN IT FOR YOU: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET REPORT CONTENT GUIDE

DELIVERED CUSTOMIZATIONS

RECENT DEVELOPMENTS

Table of Contents

Methodology

Secondary Research

Primary Research

Market Size Estimation

Data Triangulation

Market Definition

Key Stakeholders

Report Objectives

Available customizations:

Key Questions Addressed by the Report

What is the projected growth outlook for the global hemodialysis and peritoneal dialysis market through 2031?

Which region accounted for the largest share of the hemodialysis and peritoneal dialysis market in 2025?

Which hemodialysis consumable type is expected to witness the fastest growth during the forecast period?

Which hemodialysis service type is expected to grow at the highest rate through 2031?

Which peritoneal dialysis modality held the largest share of the market in 2025?

Which disease indication dominated the hemodialysis and peritoneal dialysis market in 2025?

Who are the key players operating in the global hemodialysis and peritoneal dialysis market?

Which companies are recognized as star players and emerging companies in the dialysis market?

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Adjacent Markets

Personalize This Research

Let Us Help You

TESTIMONIALS

JAYANT RAJPUROHIT

SFI Health,

BEATRIZ DE LA CALLE

Qualicaps,

Bob Williams,

Bracco Diagnostics Inc.,

Cody Coonradt,

3M Health Information Systems,

Growth opportunities and latent adjacency in Hemodialysis & Peritoneal Dialysis Market

Alejandro

Aaron

Jose